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a single cell in a given tissue involves PCR of laser-capture microdissected material 5, 6 , which is time consuming and error prone, and thus not suitable for diagnostics.
As an alternative to PCR-and hybridization-based methods, padlock probes 7 have for many years been used to analyze nucleic acids. These highly selective probes are converted into circular molecules by target-dependent ligation upon perfect hybridization to the target sequence. Circularized padlock probes can be amplified by rolling-circle amplification (RCA) in situ 8 , providing information about the localization of target molecules at the single-cell level. We have previously published a robust protocol for in situ detection of mitochondrial DNA molecules in which the target DNA is used to prime the RCA reaction 9 , causing the rolling circle product (RCP) to be anchored to the target molecule. RNA molecules can also serve as templates for the ligation of padlock probes 10 , but RNA detection with padlock probes in situ has so far proven more difficult than DNA detection and is subject to limitations 11 
(see Supplementary Note 1).
Here, we accomplish transcript detection in situ by first converting the mRNA into localized cDNA molecules that are detected with padlock probes and target-primed RCA (Fig. 1a) . With cDNA the ligation of padlock probes is highly specific, enabling genotyping increasing knowledge about the heterogeneity of mrna expression within cell populations highlights the need to study transcripts at the level of single cells. We present a method for detection and genotyping of individual transcripts based on padlock probes and in situ target-primed rolling-circle amplification. We detect a somatic point mutation, differentiate between members of a gene family and perform multiplex detection of transcripts in human and mouse cells and tissue.
In population-based assays that analyze the content of many cells, molecules in rare cells may escape detection. Furthermore, such assays provide no information concerning which of the molecules detected originate from which cells. Expression in single cells can vary substantially from the mean expression detected in a heterogeneous cell population 1,2 . Single-cell studies, preferentially with single-molecule sensitivity, are therefore essential for studying the fluctuation and sequence variation in expressed transcripts. Fluorescence in situ hybridization (FISH) has been used to detect single mRNA molecules in situ, using either probes labeled with multiple fluorophores 3 or multiple probes labeled with single fluorophores 4 . Although permitting determination of transcript copy numbers in individual cells, these techniques cannot resolve highly similar sequences, so they cannot be used to study, for example, allelic inactivation or splice variation and cannot distinguish among gene family members. The only option available for assigning transcript variants to 1 Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. 2 These authors contributed equally to this work. Correspondence should be addressed to M.N. (mats.nilsson@genpat.uu.se). brief communications of individual transcript molecules. We describe important parameters for design of primers and probes in Supplementary Notes 2 and 3 and Supplementary Figures 1 and 2 .
We first used the method to detect β-actin (ACTB) transcripts in cultured human cells with two different padlock probes, targeting sequences in the first and last exon, respectively. We obtained abundant, bright, spot-like signals localized to the cytoplasm of cells, consistent with previous observations of this transcript 3 ( Supplementary Fig. 3 ). The detection efficiency was similar for the two padlock probes, indicating that in this case detection was not highly dependent on target position along the transcript. In contrast, when reverse transcriptase was omitted from the cDNA synthesis reaction, no signals were detected, verifying that the signals were cDNA dependent. We estimated the overall in situ detection efficiency to be ~30% of available transcripts, on the basis of a comparison to quantitative PCR (qPCR) data for β-actin mRNA in the GM08402 cell line (2,000 copies per cell). There was considerable variation in the number of signals among cells ( Supplementary Fig. 4 ), consistent with other reports of intercellular variation in β-actin mRNA expression 1 .
To demonstrate high selectivity of detection, we arranged an assay for detection of single-nucleotide variants of transcripts in situ. Expressed polymorphisms are rare in β-actin, and we therefore used a single-base difference between the human and mouse β-actin sequences as genotyping target. We subjected cocultured human and mouse fibroblast cells to in situ genotyping of cDNA using padlock probes PLP-βhum (human) and PLP-βmus (Mus musculus) and target-primed RCA. There was a clear-cut distinction between the two subpopulations of cells in the coculture (Fig. 1b) . The preference for perfectly matched padlock probes at the circularization step ensures distinction between the two targets by the ligase. (Ligase fidelity is discussed in Supplementary Note 4.)
To test the method in fixed tissue sections, we targeted the closely related skeletal muscle α1-actin (Acta1) and cytoplasmic β-actin (Actb) transcripts 12 in fresh frozen tissue from an E14.5 mouse embryo cross sectioned at the level of the neck. The two actin transcripts were successfully detected in the tissue using padlock probes designed with target sequences differing by a single base. The α1-actin signals were mainly distributed to skeletal muscles, whereas β-actin signals were widely distributed but showed slightly more signals in the non-muscular tissue (Fig. 1c) . We further demonstrated the ability to distinguish three transcripts from the same gene family by including a probe specific for the cytoplasmic γ1-actin (Actg1) transcript (Supplementary Fig. 5 ).
To test the method's ability for multiplex detection of transcripts for expression profiling, we designed padlock probes for the three cancer-related transcripts HER2 (also known as ERBB2), cMyc (also known as MYC) and TERT. Using β-actin as a reference transcript, we assayed these transcripts in four cell lines (a human ovarian carcinoma cell line, a human breast carcinoma cell line, a TERT-immortalized human foreskin fibroblast cell line and a primary fibroblast cell culture). The levels of expression of the cancer-related genes differed among the cell lines ( Fig. 2a-d) . The ovarian and breast carcinoma cell lines showed similar patterns of expression of the HER2 and cMyc transcripts, whereas the TERT-immortalized fibroblast was the only cell type with a detectable level of the TERT transcript. All four cell lines expressed β-actin, and in the normal fibroblasts this was the only investigated transcript expressed at a detectable level. We compared these results to qPCR data and to available literature and found good correlation with the expected relative expression levels in the different cell lines and a notable consistency in detection efficiency among the different transcripts (Supplementary Note 5) . We noticed large cell-to-cell variation in expression for all investigated transcripts (Supplementary Fig. 6 ), which is consistent with previous studies of expression in single cells in cultures 1, 2, 11 .
We also used the technique to assess HER2 transcript distribution in a fresh frozen HER2-positive human breast cancer tissue section (Supplementary Fig. 7) . We found expression to vary widely among the cells, consistent with the expected presence of cancer cells and normal stroma in the tumor tissue.
Finally, we applied our method to genotype a KRAS point mutation in KRAS wild-type and mutant cells (Fig. 2e and  Supplementary Fig. 8 ). The different cell types could be clearly distinguished on the basis of the color of their corresponding RCPs. Activating mutations of the KRAS oncogene are found in 17%-25% of all human tumors 13 , and assays to monitor these mutations and other tumor cell-specific markers in tissue specimens in situ could be of great value for clinical pathology 
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investigations. We further investigated the potential for studies of allelic expression by analyzing 77 cells from a cell line heterozygous for a point mutation in KRAS. We observed an average allelic ratio of 48% wild-type transcripts, with considerable cellto-cell variation ( Supplementary Figs. 4b and 8d) , indicating a balanced allelic transcription. In this experiment, all heterozygous cells with more than seven RCPs showed signals from both alleles. For cells showing fewer than seven signals, it will be difficult to determine the potential for biallelic expression and extent of unbalanced allelic expression in single cells. Our method for in situ analysis of mRNA has a detection resolution that may allow the study of differences in the relative expression of two allelic transcripts directly in tissue. The importance of these types of studies was recently highlighted in two papers describing large-scale analyses of allele-specific expression 14, 15 , revealing that many genes undergo this type of transcriptional regulation and that the allelic expression can differ among tissues. Furthermore, it has been shown that most human genes undergo alternative splicing 16 , which could now also potentially be studied at the single-cell level using this method. Because to our knowledge no other in situ method exists today that can perform multiplex detection of expressed single nucleotide sequence variants, we believe that our method to visualize transcriptional variation directly in cells and tissues will be of value in both research and diagnostics, providing new insights about the human transcriptome. methods Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/. online methods Cell culture. The cell lines GM08402 (Coriell Cell Repositories) and BJhTERT were cultured in MEM without phenol red and l-glutamine (Gibco) supplemented with 10% FBS (Sigma), 1× nonessential amino acids (Gibco), 2 mM l-glutamine (Sigma) and 1× penicillin-streptomycin (PEST, Sigma). Mouse embryonic fibroblasts (MEF) were cultured in DMEM without phenol red and l-glutamine (Gibco) supplemented with 10% FBS, 2 mM l-glutamine and 1× PEST. ONCO-DG-1, SW-480, A-427 (all three from DSMZ), SKOV3 and SKBR3 were cultured in RPMI culture medium (Sigma) supplemented with 10% FBS, 2 mM l-glutamine and 1× PEST.
Preparation of tissue sections. Fresh frozen 9-µm sections of E14.5 mouse embryos were placed on Superfrost Plus Gold slides (Thermo Scientific). Fully anonymized fresh frozen human tissue sections from a HER2-positive breast cancer were obtained from the Fresh Tissue Biobank at the Department of Pathology, Uppsala University Hospital, in accordance with the Swedish Biobank Legislation. Breast tissue sections of 4 µm thickness were placed on Starfrost microscope slides (Instrumedics).
Sample pretreatment for in situ experiments. Cells were seeded on Superfrost Plus slides (Thermo Scientific) and allowed to attach. When the cells reached the desired confluency they were fixed in 3% (w/v) paraformaldehyde (Sigma) in PBS for 30 min at room temperature (20-23 °C). After fixation, slides were washed twice in DEPC-treated PBS (DEPC-PBS) and dehydrated through a series of 70%, 85% and 99.5% ethanol for 3 min each. The molecular reactions were performed in Secure-seals (Grace Bio-Labs, 9 mm in diameter and 0.8 mm deep) attached to the slides. A 50-µl reaction volume was used for each sample. To make the RNA more readily available for cDNA synthesis, 0.1 M HCl was applied to the cells for 10 min at room temperature. This was followed by two brief washes in DEPC-PBS.
Tissues were treated similarly to cell lines, with a few exceptions. Tissue fixation was performed in 2% (w/v) paraformaldehyde in PBS. The tissue was then permeabilized with 0.01% pepsin (Sigma) in 0.1 M HCl at 37 °C for 2 min. Molecular reactions were carried out with a reaction volume of 100 µl in Secure-seals (13 mm in diameter, 0.8 mm deep; Grace Bio-Labs) mounted over the tissue. Reverse transcription was carried out overnight and incubation times for ligation, RCA and detection probe hybridization were doubled. For the mouse tissue, ligation was carried out with T4 DNA ligase.
Oligonucleotide sequences. Oligonucleotide sequences (Supplementary Tables 1-3 ) were designed using GenBank accession numbers NM_001101.3 (ACTB), NM_007393.3 (Actb), NM_198253.2 (TERT), NM_002467 (MYC), NM_001005862.1 (ERBB2), NM_009606 (Acta1), NM_009609 (Actg1) and NM_ 033360 (KRAS). All padlock probes were 5′-phosphorylated at a concentration of 2 µM with 0.2 U µl −1 T4 polynucleotide kinase (Fermentas) in the manufacturer's buffer A plus 1 mM ATP for 30 min at 37 °C, followed by 10 min at 65 °C. For β-actin transcript detection in cultured cells, primer P-βe1 was used for detection with padlock probe PLP-βe1, primer P-βe6 with padlock probe PLP-βe6, primer P-βhum with padlock probe PLP-βhum and primer P-βmus with padlock probe PLP-βmus unless otherwise indicated. TERT was detected with primer P-TERT and padlock probe PLP-TERT, cMyc with primer P-cMyc and padlock probe PLP-cMyc and HER2 with primer P-HER2 and padlock probe PLP-HER2. For detection of transcripts in mouse tissue, primer P-α1βmus was used with padlock probe PLP2-βmus for β-actin and with padlock probe PLP-α1mus for α1-actin, and primer P-γ1mus was used together with padlock probe PLP-γ1mus for γ1-actin detection. For KRAS genotyping, primer P-KRAS was used in combination with the padlock probes PLP-KRAS-wtGGT, PLP-KRAS-mutGTT and PLP-KRAS-mutGAT.
In situ cDNA detection procedure. Samples were preincubated in M-MuLV reaction buffer. Then 1 µM of cDNA primer was added to the slides with 20 U µl −1 of RevertAid H minus M-MuLV reverse transcriptase (Fermentas), 500 nM dNTPs (Fermentas), 0.2 µg µl −1 BSA (NEB) and 1 U µl −1 RiboLock RNase Inhibitor (Fermentas) in the M-MuLV reaction buffer. Slides were incubated for 3 h to overnight at 37 °C. After incubation, slides were washed briefly in PBS-T (DEPC-PBS with 0.05% Tween-20 (Sigma)), followed by a postfixation step in 3% (w/v) paraformaldehyde in DEPC-PBS for 30 min at room temperature. After postfixation, the samples were washed twice in PBS-T.
To make the target cDNA strands available for padlock probe hybridization, the RNA portion of the created RNA-DNA hybrids was degraded with ribonuclease H. This was performed in the same step as the padlock probe hybridization and ligation. For most reactions, Ampligase (Epicentre) was used for ligation. Samples were first preincubated in Ampligase buffer (20 mM Tris-HCl, pH 8.3, 25 mM KCl, 10 mM MgCl 2 , 0.5 mM NAD and 0.01% Triton X-100). Ligation was then carried out with 100 nM of each padlock probe in a mix of 0.5 U µl −1 Ampligase, 0.4 U µl −1 RNase H (Fermentas), 1 U µl −1 RiboLock RNase Inhibitor, Ampligase buffer, 50 mM KCl and 20% formamide. Incubation was performed first at 37 °C for 30 min, followed by 45 min at 45 °C. For detection of actin transcript isoforms in mouse embryonic tissue sections, ligation was instead carried out using T4 DNA ligase (Fermentas). Samples were then first preincubated in T4 DNA ligase buffer (Fermentas). Then 100 nM of each padlock probe was added with 0.1 U µl −1 T4 DNA ligase, 0.4 U µl −1 RNase H, 1 U µl −1 RiboLock RNase Inhibitor and 0.2 µg µl −1 BSA in T4 DNA ligase buffer supplemented with 0.5 mM ATP and 250 mM NaCl. Slides were then incubated at 37 °C for 30 min. After ligation with Ampligase or T4 DNA ligase, slides were washed in DEPC-treated 2× SSC with 0.05% Tween-20 at 37 °C for 5 min and rinsed in PBS-T.
Slides were preincubated briefly in Φ29 DNA polymerase buffer (Fermentas). RCA was then performed with 1 U µl −1 Φ29 DNA polymerase (Fermentas) in the supplied reaction buffer, 1 U µl −1 RiboLock RNase Inhibitor, 250 µM dNTPs, 0.2 µg µl −1 BSA and 5% glycerol. Incubation was carried out for 60 min at 37 °C. The incubation was followed by a wash in PBS-T.
RCPs were visualized using 100 nM of each corresponding detection probe in 2× SSC and 20% formamide at 37 °C for 30 min. Slides were then washed in PBS-T, the Secure-seals were removed and the slides were dehydrated using a series of 70%, 85% and 99.5% ethanol for 3 min each. The dry slides were mounted with Vectashield (Vector), containing 100 ng ml −1 DAPI to counterstain the cell nuclei. The protocol for counterstaining of cell membranes in Supplementary Figure 3 is described in Supplementary Note 6.
